Rothblatt, United Therapeutics CEO, sells $5.1m in UTHR stock

Martine Rothblatt, Chairperson & CEO of United Therapeutics Corp (NASDAQ:UTHR), sold approximately $5.1 million worth of company stock on March 25, 2026, while also exercising stock options for 9,500 shares. These transactions were executed under a pre-arranged 10b5-1 trading plan. The article also highlights recent company news, including a $2 billion share repurchase program and positive results from a phase 3 study for nebulized Tyvaso.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin